Follow
Luis Escribano
Luis Escribano
Associated Researcher, Universidad de Salamanca
Verified email at usal.es
Title
Cited by
Cited by
Year
WHO classification of tumours of haematopoietic and lymphoid tissues
E Campo, NL Harris, ES Jaffe, SA Pileri, H Stein, J Thiele, JW Vardiman
International agency for research on cancer 2, 439, 2008
23281*2008
Diagnostic criteria and classification of mastocytosis: a consensus proposal
P Valent, HP Horny, L Escribano, BJ Longley, CY Li, LB Schwartz, ...
Leukemia research 25 (7), 603-625, 2001
13222001
Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria
P Valent, C Akin, L Escribano, M Födinger, K Hartmann, K Brockow, ...
European journal of clinical investigation 37 (6), 435-453, 2007
8892007
Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal
P Valent, C Akin, M Arock, K Brockow, JH Butterfield, MC Carter, ...
International archives of allergy and immunology 157 (3), 215-225, 2012
6772012
KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA …
AC Garcia-Montero, M Jara-Acevedo, C Teodosio, ML Sanchez, R Nunez, ...
Blood 108 (7), 2366-2372, 2006
5722006
Cutaneous manifestations in patients with mastocytosis: consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma …
K Hartmann, L Escribano, C Grattan, K Brockow, MC Carter, ...
Journal of Allergy and Clinical Immunology 137 (1), 35-45, 2016
4112016
Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients
L Escribano, I Álvarez-Twose, L Sánchez-Muñoz, A Garcia-Montero, ...
Journal of allergy and clinical immunology 124 (3), 514-521, 2009
3092009
Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and …
M Ocqueteau, A Orfao, J Almeida, J Bladé, M Gonzalez, R García-Sanz, ...
The American journal of pathology 152 (6), 1655, 1998
3081998
Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implications
L Escribano, A Orfao, B Dıaz-Agustin, J Villarrubia, C Cerveró, A López, ...
Blood, The Journal of the American Society of Hematology 91 (8), 2731-2736, 1998
2851998
Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria
P Valent, C Akin, WR Sperr, L Escribano, M Arock, HP Horny, JM Bennett, ...
Leukemia research 27 (7), 635-641, 2003
2772003
KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis
M Arock, K Sotlar, C Akin, S Broesby-Olsen, G Hoermann, L Escribano, ...
Leukemia 29 (6), 1223-1232, 2015
2762015
Diagnosis and treatment of cutaneous mastocytosis in children: practical recommendations
M Castells, DD Metcalfe, L Escribano
American journal of clinical dermatology 12, 259-270, 2011
2762011
Recent advances in the understanding of mastocytosis: the role of KIT mutations*
A Orfao, AC Garcia‐Montero, L Sanchez, L Escribano
British journal of haematology 138 (1), 12-30, 2007
2762007
Mastocytosis: current concepts in diagnosis and treatment
L Escribano, C Akin, M Castells, A Orfao, D Metcalfe
Annals of hematology 81, 677-690, 2002
2752002
Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms
I Álvarez-Twose, DG de Olano, L Sánchez-Muñoz, A Matito, ...
Journal of allergy and clinical immunology 125 (6), 1269-1278. e2, 2010
2732010
Advances in the classification and treatment of mastocytosis: current status and outlook toward the future
P Valent, C Akin, K Hartmann, G Nilsson, A Reiter, O Hermine, K Sotlar, ...
Cancer research 77 (6), 1261-1270, 2017
2712017
Mastocytosis: pathology, genetics, and current options for therapy
P Valent, C Akin, W Sperr, M Mayerhofer, M Födinger, R Fritsche-Polanz, ...
Leukemia & lymphoma 46 (1), 35-48, 2005
2682005
Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease
WR Sperr, JH Jordan, M Fiegl, L Escribano, C Bellas, S Dirnhofer, ...
International archives of allergy and immunology 128 (2), 136-141, 2002
2442002
Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis
WR Sperr, L Escribano, JH Jordan, GH Schernthaner, M Kundi, HP Horny, ...
Leukemia research 25 (7), 529-536, 2001
2392001
One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes
K Sotlar, L Escribano, O Landt, S Möhrle, S Herrero, A Torrelo, U Lass, ...
The American journal of pathology 162 (3), 737-746, 2003
2282003
The system can't perform the operation now. Try again later.
Articles 1–20